| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 13.274 | 26.030 | 24.717 | 24.955 | 24.006 | 30.865 | 9.654 | 6.464 |
| Total Income - EUR | - | - | 13.274 | 26.030 | 24.717 | 24.955 | 24.006 | 47.926 | 9.654 | 6.464 |
| Total Expenses - EUR | - | - | 1.047 | 5.202 | 12.620 | 10.233 | 14.097 | 15.127 | 3.438 | 4.987 |
| Gross Profit/Loss - EUR | - | - | 12.227 | 20.828 | 12.098 | 14.722 | 9.909 | 32.798 | 6.216 | 1.478 |
| Net Profit/Loss - EUR | - | - | 11.831 | 20.202 | 11.356 | 13.974 | 9.371 | 31.562 | 5.371 | 1.267 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biovision System Technology Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 22.736 | 16.417 | 12.460 | 8.615 | 0 | 0 | 37.418 |
| Current Assets | - | - | 12.379 | 27.003 | 42.789 | 58.186 | 67.641 | 99.661 | 105.575 | 93.822 |
| Inventories | - | - | 0 | 32 | 0 | 0 | 0 | 2.276 | 0 | 2.044 |
| Receivables | - | - | 175 | 26.971 | 26.369 | 25.858 | 61.672 | 97.350 | 97.054 | 82.664 |
| Cash | - | - | 12.204 | 0 | 16.421 | 32.328 | 5.969 | 35 | 8.520 | 9.113 |
| Shareholders Funds | - | - | 11.875 | 31.858 | 42.598 | 55.764 | 63.898 | 95.659 | 100.739 | 101.443 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 505 | 17.881 | 16.609 | 14.883 | 12.357 | 4.002 | 4.836 | 29.796 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9522 - 9522" | |||||||||
| CAEN Financial Year |
9522
|
|||||||||
Comments - Biovision System Technology Srl